Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

19.93
BATS BZX Real-Time Price
As of 10:04am ET
 +0.36 / +1.84%
Today’s Change
9.68
Today|||52-Week Range
19.96
+101.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues39.0M29.6M33.8M63.7M
 
 
 
 
 
Cost of Goods Sold7.4M6.9M7.2M7.8M
 
 
 
 
 
Depreciation And Amortization644.0K602.0K600.0K500.0K
 
 
 
 
 
 
Operating ExpensesGross Income31.0M22.0M26.0M55.4M
 
 
 
 
 
General Expenses53.6M49.6M51.4M47.3M
 
 
 
 
 
Research And Development41.3M36.9M38.3M34.0M
 
 
 
 
 
Total Operating Expenses61.6M57.1M59.2M55.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.6M-27.5M-25.5M8.1M
 
 
 
 
 
Interest Expense On Debt5.6M5.4M5.5M5.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.8M-32.7M-30.6M3.3M
 
 
 
 
 
Income Taxes-422.0K-210.0K-180.0K-580.0K
 
 
 
 
 
Net Income-27.4M-32.9M-30.8M2.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS128.2M128.6M134.0M141.2M
 
 
 
 
 
Shares To Calculate EPS Diluted128.2M128.6M134.0M143.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.26-$0.23$0.02
 
 
 
 
 
EPS Diluted-$0.21-$0.26-$0.23$0.02